tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Advanced Medical Solutions Confirms Current Share Capital and Voting Rights

Story Highlights
  • Advanced Medical Solutions has 219,584,690 ordinary shares in issue with voting rights.
  • The updated share count guides investors’ disclosure duties under UK transparency rules.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Advanced Medical Solutions Confirms Current Share Capital and Voting Rights

Claim 50% Off TipRanks Premium

Advanced Medical Solutions ( (GB:AMS) ) just unveiled an announcement.

Advanced Medical Solutions Group has confirmed that its issued share capital as of 30 January 2026 consists of 219,584,690 ordinary shares of 5p each, all carrying voting rights and with no shares held in treasury. This figure sets the reference point shareholders must use when calculating whether their holdings trigger disclosure obligations under UK financial transparency rules, providing clarity on the company’s capital structure and ensuring investors can accurately assess and report their positions in accordance with regulatory requirements.

The most recent analyst rating on (GB:AMS) stock is a Hold with a £247.00 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.

Spark’s Take on GB:AMS Stock

According to Spark, TipRanks’ AI Analyst, GB:AMS is a Neutral.

Advanced Medical Solutions shows strong revenue growth and a solid capital structure, but faces challenges with declining profitability margins. Technical indicators suggest a positive trend, though valuation metrics indicate potential overvaluation. Recent corporate events highlight growth potential through strategic acquisitions and investor engagement.

To see Spark’s full report on GB:AMS stock, click here.

More about Advanced Medical Solutions

Advanced Medical Solutions Group is a UK-based medical device company specialising in tissue-healing products, including adhesives, sealants, biosurgical devices and sutures. By combining advanced material science with applicator design in partnership with surgeons and key opinion leaders, the group aims to deliver clinically and commercially competitive solutions that improve patient outcomes while maintaining affordability. Its diversified product and geographic mix, strengthened by the acquisition of Peters Surgical, underpins a scalable, capital-efficient growth strategy focused on surgical products, international expansion and margin enhancement.

Average Trading Volume: 597,508

Technical Sentiment Signal: Buy

Current Market Cap: £475.8M

See more insights into AMS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1